Dermawell Pharmaceuticals Private Limited

Dermawell Pharmaceuticals Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U36100DL2009PTC196601 Incorporated 03 December 2009 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2024
₹11.78 Lakh
▲ 152% YoY
Net loss · FY 2024
₹41,318
Net margin -3.5%
EBITDA · FY 2024
-₹41,318
EBITDA margin -3.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
3
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Dermawell Pharmaceuticals Private Limited

Data last updated:

Dermawell Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 03 December 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36100DL2009PTC196601.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amit Seth and Deepali Seth.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 308 Defence Colony, New Delhi, Delhi, India – 110024.

As per the financials filed for FY 2024, the company reported a revenue of ₹11.78 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹41,318 (net margin -3.5%) and EBITDA of -₹41,318 (EBITDA margin -3.5%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years and 20% over five years.

Dermawell Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0051948). The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U36100DL2009PTC196601
Registration Number 196601
Incorporation Date 03 December 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Non-Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0051948
Key People
Sanjay Midha Additional Director Amit Seth Director Deepali Seth Director

Recognitions & Rankings of Dermawell Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-08-0051948

Contact details

Dermawell Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C – 308 Defence Colony, New Delhi, Delhi, India – 110024
  • Industry
    Healthcare, Other Hospital And Medical Care Activities

To see the full contact details of Dermawell Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Dermawell Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Dermawell Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Dermawell Pharmaceuticals Private Limited, buy the company report.

Financials of Dermawell Pharmaceuticals Private Limited

FY 2024 filings available

Dermawell Pharmaceuticals Private Limited reported revenue of ₹11.78 Lakh (up 152% YoY) for FY 2024.

Revenue · FY 2024
₹11.78 Lakh ▲ 152%
Net loss · FY 2024
₹41,318 margin -3.5%
EBITDA · FY 2024
-₹41,318 margin -3.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 152%
3 years · compounded
▲ 74%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 121%
3 years · compounded
▼ 13%
5 years · compounded
▼ 21%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 152% growth in the latest year. EBITDA fell 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹41,318
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹41,318
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-3.5%
Net Profit Margin-3.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dermawell Pharmaceuticals Private Limited, buy the company report.

Board of directors of Dermawell Pharmaceuticals Private Limited

Dermawell Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay MidhaAdditional Director25 Oct 201115 Years 0 MonthsCurrent
Amit SethDirector03 Dec 200916 Years 11 MonthsCurrent
Deepali Seth
Also directs: I4climate Private Limited
Director03 Dec 200916 Years 11 MonthsCurrent
View all directors

Auditor

Dermawell Pharmaceuticals Private Limited is audited by PRAMOD PANDA & CO. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
PRAMOD PANDA & CO.FY 2017326176E

Shareholding

The shareholding of Dermawell Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dermawell Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dermawell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Dermawell Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Dermawell Pharmaceuticals Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Sanjay Midha was appointed as Additional Director on 25 Oct 2011.

AGM
Dermawell Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Dermawell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Appointed
Sanjay Midha was appointed as Additional Director.
Appointed
Amit Seth was appointed as Director.
Appointed
Deepali Seth was appointed as Director.
Incorporation
03 Dec 2009
Dermawell Pharmaceuticals Private Limited was registered on 03 Dec 2009 with Roc Delhi I & aged 16 years 11 months as per MCA records.

Frequently asked questions

Dermawell Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 03 December 2009 (17+ years old) and is registered under CIN U36100DL2009PTC196601.

Dermawell Pharmaceuticals has 3 current directors:

The latest financial statements of Dermawell Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Dermawell Pharmaceuticals is U36100DL2009PTC196601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dermawell Pharmaceuticals was incorporated on 03 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.

Sanjay Midha was appointed as Additional Director on 25 Oct 2011. Amit Seth was appointed as Director on 03 Dec 2009. Deepali Seth was appointed as Director on 03 Dec 2009.

Yes, Dermawell Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0051948).

The registered office of Dermawell Pharmaceuticals is at C – 308 Defence Colony, New Delhi, Delhi, India – 110024.

Dermawell Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.

The compliance status of Dermawell Pharmaceuticals is active non-compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.